dc.creatorCalvo, Natalia Lorena
dc.creatorMaggio, Ruben Mariano
dc.creatorKaufman, Teodoro Saul
dc.date.accessioned2018-06-28T15:28:16Z
dc.date.available2018-06-28T15:28:16Z
dc.date.created2018-06-28T15:28:16Z
dc.date.issued2018-01
dc.identifierCalvo, Natalia Lorena; Maggio, Ruben Mariano; Kaufman, Teodoro Saul; Characterization of pharmaceutically relevant materials at the solid state employing chemometrics methods; Elsevier Science; Journal of Pharmaceutical and Biomedical Analysis; 147; 1-2018; 538-564
dc.identifier0731-7085
dc.identifierhttp://hdl.handle.net/11336/50361
dc.identifierCONICET Digital
dc.identifierCONICET
dc.description.abstractThe understanding of materials and processes is a requirement when it comes to build quality into pharmaceutical products. This can be achieved through the development of rapid, efficient and versatile analytical methods able to perform qualification or quantification tasks along the manufacturing and control process. Process monitoring, capable of providing reliable real-time insights into the processes performance during the manufacturing of solid dosage forms, are the key to improve such understanding. In response to these demands, in recent times multivariate chemometrics algorithms have been increasingly associated to different analytical techniques, mainly vibrational spectroscopies [Raman, mid-infrared (MIR), near-infrared (NIR)], but also ultraviolet-visible (UV-vis) spectroscopy, X-ray powder diffraction and other methodologies. The resulting associations have been applied to the characterization and evaluation of different aspects of pharmaceutical materials at the solid state. This review examines the different scenarios where these methodological marriages have been successful. The list of analytical problems and regulatory demands solved by chemometrics analysis of solid-state multivariate data covers the whole manufacturing and control processes of both, active pharmaceutical ingredients in bulk and in their drug products. Hence, these combinations have found use in monitoring the crystallization processes of drugs and supramolecular drug associations (co-crystals, co-amorphous and salts), to access the correct crystal morphology, particle size, solubility and dissolution properties. In addition, they have been applied to identify and quantitate specific compounds, mainly active pharmaceutical ingredients in complex solid state mixtures. This included drug stability against different stimuli, solid-state transformations, or detection of adulterated or fraudulent medicines. The use of chemometrics-assisted analytical methods as part of the modern concept of process analytical technology, where every process step of every product batch from raw materials to final product must take place in a controlled manner is discussed. Finally, but no less important, the application of chemometrics methods to chemical imaging, aiming to extract spatial and compositional information is also revised.
dc.languageeng
dc.publisherElsevier Science
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jpba.2017.06.017
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0731708517312438
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectCHARACTERIZATION OF THE SOLID-STATE
dc.subjectCHEMICAL IMAGING
dc.subjectCHEMOMETRICS
dc.subjectPAT
dc.subjectQUALITY CONTROL AND STABILITY
dc.subjectVIBRATIONAL SPECTROSCOPIES AND XRPD
dc.titleCharacterization of pharmaceutically relevant materials at the solid state employing chemometrics methods
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:ar-repo/semantics/artículo
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución